Yong-Li Zhong

This inventor holds 19 USPTO granted patents and 1 published patent application and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Idenix Pharmaceuticals, Inc., Merck Sharp & Dohme LLC. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong-Li Zhong. Retrieved from https://idiyas.com/inventor/yong-li-zhong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 9.8

ph-index = 7

Forward Citations = 126(Granted Patents)

Company Filing History:

20 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 100

Idenix Pharmaceuticals, Inc.

patents

1 out of 70

Merck Sharp & Dohme LLC

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Beta 3 Agonists

CGRP Antagonists

Macrolactams

Phosphoramidate Compounds

Synthetic Pathways

Chiral Derivatives

Nucleoside Compounds

Intermediates

Orexin Receptor Antagonists

Synthetic Processes

Drug Development

Pharmaceutical Intermediates

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12709595 - NOVEL SYNTHETIC PATHWAY TO BELZUTIFAN (2026-08-18),

2. 11767292 - Process for making beta 3 agonists and intermediates (2023-09-26),

3. 11708371 - Process for making beta 3 agonists and intermediates (2023-07-25),

4. 11124478 - Process for making beta 3 agonists and intermediates (2021-09-21),

5. 10899771 - Process for making beta 3 agonists and intermediates (2021-01-26),

6. 10577316 - Process for making beta 3 agonists and intermediates (2020-03-03),

7. 10526363 - Substituted phosphoramidate compounds and uses thereof (2020-01-07),

8. 10435410 - Process for making beta 3 agonists and intermediates (2019-10-08),

9. 10251903 - Process for making nucleoside phosphoramidate compounds (2019-04-09),

10. 10106541 - Intermediates for preparing CGRP receptor antagonists (2018-10-23),

11. 10087189 - Process for making beta 3 agonists and intermediates (2018-10-02),

12. 9873707 - Methods and intermediates for preparing macrolactams (2018-01-23),

13. 9850246 - Process for making CGRP receptor antagonists (2017-12-26),

14. 9822121 - Process for making beta 3 agonists and intermediates (2017-11-21),

15. 9809536 - Process for making beta 3 agonists and intermediates (2017-11-07),

Title: The Inventor Profile of Yong-Li Zhong

Introduction: Yong-Li Zhong is a prolific inventor based in Edison, NJ, known for his groundbreaking contributions to various technological fields.

Latest Patents: Yong-Li Zhong holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Yong-Li Zhong has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Yong-Li Zhong has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Yong-Li Zhong's dedication to pushing the boundaries of technology and his passion for creating solutions to complex problems make him a standout figure in the world of inventions and innovations.

Profile summary based on public USPTO records.